---
title: NEW funding opportunities for small businesses & big thinkers 💼
---

Plus: An EVIDENT investment in mental health 🧠 | RAMMP mobility system hits the streets ♿| 1-CURE on the radio 📻 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­    ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

| View in browser Thursday, April 23, 2026 \| 3 minutes and 6 seconds or ~186 heartbeats In this week’s Vitals, we introduce the teams changing the game for mental health in America. Plus—we check out a next-gen mobility device hitting the streets of Pittsburgh and tune into ARPA-H insights hitting the radio waves. But first... ARPA-H has 2️⃣ new chances to transform health! We’re looking for... 🔎  ...small businesses with big ideas 💼 ARPA-H supports a comprehensive ecosystem for innovative health research and development projects. That includes nimble small businesses ready to solve the biggest problems in health! Visit our small business webpage to read the latest draft solicitation with new topics for our Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. You can also sign up for a Proposers’ Day on June 11.  ...hot concepts in tissue preservation 🫁 Right now, we can't keep donated tissues and organs viable for long. That limits transplants, slows regenerative medicine, and costs lives. The new Technology Integrator and Accelerator (TIGAR) is built to change that. TIGAR will evaluate concepts that can accelerate progress towards long-term banking of complex tissues at practical temperatures. Watch this video to learn more and sign up for an informational webinar on May 14. Our investment in mental health is EVIDENT 😌 Nearly 50% of Americans will suffer from a behavioral or mental health disorder in their lifetime, with even higher numbers for veterans. For many, the path to treatment becomes an ongoing cycle of trial and error, waitlists, check-ins, and for millions of patients, it still falls short. ARPA-H's Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health (EVIDENT) program is working to move beyond trial-and-error care through personalized, data-driven approaches.     EVIDENT will collectively fund up to $139.4 million to help spur new, effective therapies for behavioral health. As part of the Trump Administration’s Executive Order to Accelerate Medical Treatments for Serious Mental Illness, EVIDENT will allocate at least $50 million to match state government investments in psychedelic research for populations with serious mental illness.     The program will catalyze a new era in mental and behavioral health by developing and validating FDA-ready clinical endpoints to help bring new rapid-acting therapies such as digital interventions, neuromodulation, and neuroplastogens, including the safe use of psychedelics.    From the ARPA-H Director: “These awards are a critical step toward faster relief, fewer failed treatment attempts, and a future where behavioral health care is as measurable and precise as other areas of medicine,” said ARPA-H Director Dr. Alicia Jackson.    Read on to meet the research teams making this bold vision a reality.  Elsewhere in the ARPAsphere: Thank you, Dallas! You showed us what going big is all about 🤠 Earlier this month, ARPA-H leaders met with the brightest minds in Dallas-area biotech, and we can confirm that innovation is alive and well in Texas! After meeting ARPA-H performers bioprinting livers and manufacturing high-tech therapeutic implants, we left inspired to innovate, collaborate, and make the impossible possible. Feel the energy for yourself in our recap video.  Excitement is RAMMPing up ♿ At ARPA-H, we're not spinning our wheels. We're turning the future of mobility on its head. On Tuesday, ARPA-H performers at the University of Pittsburgh demonstrated the pioneering Robotic Assisted Mobility and Manipulation Platform (RAMMP). This AI-powered mobility prototype can navigate uneven terrain, open doors, and help people who use wheelchairs live safer and more independent lives. See RAMMP in action and read all about it in the Pittsburgh Post-Gazette.   1-CURE on the radio 📻 No static here—our science is coming in loud and clear! Listen to Program Manager (PM) Dr. Wilfred Ngwa discuss the new One Comprehensive Universal Radiotherapy for Everyone (1-CURE) program and the future of cancer treatment on The Federal Drive. Now live: New ARPA-H Solutions site features 💻 Returning users to the ARPA-H Solutions site will log in with their Google or Microsoft account, providing faster, modern authentication options. Just continue to use the same email address to access event registrations, prior submissions, application statuses, and saved drafts.  Before you go... Share your big idea to STOMP out microplastics🔬 Yesterday, innovators gathered at the Systematic Targeting Of MicroPlastics (STOMP) Proposers’ Day to envision the definitive toolbox for measuring, researching, and affordably removing microplastics and nanoplastics in the human body. Whether you were in attendance or not, you can be part of the solution! Check out the STOMP program page to ask a question or share a teaming profile. Solution summaries are due May 6.  You received this email because you expressed an interest in ARPA-H. If you are not interested in receiving intermittent emails with ARPA-H news and events, please unsubscribe below.    Was this newsletter forwarded to you? Sign up here to receive weekly updates. Connect with us.             Interested in leading biomedical research that could change the world? Learn more at arpa-h.gov. Note: HubSpot may collect geolocation data and time zone; IP address, time, and date of signup and opt-in confirmation. ARPA-H, 1301 K St., 1200W, Washington, DC 20005, United States Unsubscribe Manage preferences Copyright © 2025 ARPA-H, All rights reserved. |
| --- |